2BB score and signals
Aquestive Therapeutics, Inc.’s current 2BB score is 41 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 50 | Moderate |
| Momentum | 52 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 97 | Very Strong |
| Risk | 72 | High |
Company facts
| Headquarters | Warren, New Jersey, United States |
| Founded | 2004 |
| Employees | 147 |
| 52-week range | $2.93 – $7.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-02 | — | -0.1396 | — | $10.96M |
| 2026-11-03 | — | -0.118 | — | $11.24M |
| 2026-08-11 | -0.18 | -0.1054 | $13.82M | $11.65M |
| 2026-05-13 | -0.07 | -0.1399 | $14.45M | $11.11M |
Related companies
2BBBullish & Bearish